Healthcare Stocks Surge as Investors Rotate Away From Tech
AbbVie, Eli Lilly, and J&J are hitting all-time highs as money flows out of tech and into pharma.
The rotation is real and it's happening fast. Healthcare stocks are quietly becoming the go-to trade for investors who've had enough of tech volatility, and the numbers are starting to back that up in a big way.
AbbVie, Eli Lilly, and Johnson & Johnson were all on pace to close at all-time highs on Friday. That's not a coincidence — that's a signal. When three pharma heavyweights hit record territory on the same day, the market is telling you something about where the smart money is moving.
Read more OpenAI IPO Odds: Traders Bet on 2027 Over 2026 →
Biopharmaceuticals in particular are drawing renewed appetite from investors. The sector offers something tech has struggled to deliver lately: relative stability, dividend income, and fundamentals that don't depend on AI hype cycles or interest-rate sensitivity the same way growth stocks do. For traders looking to stay long equities without eating another gut-punch from Nasdaq swings, healthcare is looking like a credible alternative right now.
This kind of sector rotation often signals a broader shift in market sentiment — from offense to something closer to defense with upside. Healthcare isn't traditionally thought of as a momentum play, but that's exactly what it's becoming. If you're still overweight tech and underweight pharma, Friday's price action is worth paying attention to.
Continue reading at MarketWatch.com
